{"id":62390,"date":"2025-12-20T04:06:01","date_gmt":"2025-12-20T03:06:01","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\/"},"modified":"2025-12-20T04:06:01","modified_gmt":"2025-12-20T03:06:01","slug":"ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\/","title":{"rendered":"CCAGW Releases Statement Opposing Inclusion of MFN in New CMMI Models"},"content":{"rendered":"
\n

WASHINGTON–(BUSINESS WIRE)–#congress<\/a>–Today, Council for Citizens Against Government Waste (CCAGW) President Tom Schatz issued the following statement in response to the announcement of two proposed Center for Medicare and Medicaid Innovation (CMMI) models, \u201cGLOBE\u201d and \u201cGUARD,\u201d that seek to advance so-called \u2018most favored nation\u2019 (MFN) drug price controls:\n<\/p>\n

<\/a>
<\/a><\/p>\n

\n\u201cCCAGW is disappointed to see the administration push price controls into our healthcare system through an Obamacare era program that has proven to be a costly, unaccountable experiment in government-controlled healthcare. The proposed GLOBE and GUARD models double down on the problem by advancing a flawed big-government solution through a wasteful, big-government agency. These new models should be stopped before they burden patients with more disruptive changes to their care and displace competitive market solutions with more inefficient bureaucracy.\u201d\n<\/p>\n

\n\u201cCMMI was created to test models that improve care and lower costs. Instead, it has disrupted patient access, undermined providers, operated with little accountability, and wasted billions of taxpayer dollars. Using this failed agency to import foreign price controls from countries with socialized medicine is not only contrary to conservative principles but also compounds the damage.\u201d\n<\/p>\n

\n\u201cCountries that rely on government-controlled drug prices experience fewer new treatments, longer delays, and reduced access to lifesaving medicines. The U.S. should not follow that path, especially through an agency with CMMI\u2019s record of failure.\u201d\n<\/p>\n

\n\u201cCMMI has had 15 years to prove it can work, but it has failed miserably. Rather than allowing CMMI to expand its reach through models like GLOBE and GUARD, policymakers should advance alternative solutions that actually lower out-of-pocket costs for patients and consumers.\u201d\n<\/p>\n

\nThe Council for Citizens Against Government Waste<\/a> is the lobbying arm of Citizens Against Government Waste, the nation\u2019s largest nonpartisan, nonprofit organization dedicated to eliminating waste, fraud, abuse, and mismanagement in government.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nAlexandra Abrams<\/b>
(202) 467-5310<\/b>
aabrams@cagw.org<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

WASHINGTON–(BUSINESS WIRE)–#congress–Today, Council for Citizens Against Government Waste (CCAGW) President Tom Schatz issued the following statement in response to the announcement of two proposed Center for Medicare and Medicaid Innovation (CMMI) models, \u201cGLOBE\u201d and \u201cGUARD,\u201d that seek to advance so-called \u2018most favored nation\u2019 (MFN) drug price controls: \u201cCCAGW is disappointed to see the administration push … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62390","6":"format-standard","7":"category-industry"},"yoast_head":"\nCCAGW Releases Statement Opposing Inclusion of MFN in New CMMI Models - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CCAGW Releases Statement Opposing Inclusion of MFN in New CMMI Models - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"WASHINGTON–(BUSINESS WIRE)–#congress–Today, Council for Citizens Against Government Waste (CCAGW) President Tom Schatz issued the following statement in response to the announcement of two proposed Center for Medicare and Medicaid Innovation (CMMI) models, \u201cGLOBE\u201d and \u201cGUARD,\u201d that seek to advance so-called \u2018most favored nation\u2019 (MFN) drug price controls: \u201cCCAGW is disappointed to see the administration push ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-20T03:06:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251219605858\/en\/793198\/22\/CouncilCAGW-Logo-Color.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"CCAGW Releases Statement Opposing Inclusion of MFN in New CMMI Models\",\"datePublished\":\"2025-12-20T03:06:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\\\/\"},\"wordCount\":315,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251219605858\\\/en\\\/793198\\\/22\\\/CouncilCAGW-Logo-Color.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\\\/\",\"name\":\"CCAGW Releases Statement Opposing Inclusion of MFN in New CMMI Models - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251219605858\\\/en\\\/793198\\\/22\\\/CouncilCAGW-Logo-Color.jpg\",\"datePublished\":\"2025-12-20T03:06:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251219605858\\\/en\\\/793198\\\/22\\\/CouncilCAGW-Logo-Color.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251219605858\\\/en\\\/793198\\\/22\\\/CouncilCAGW-Logo-Color.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CCAGW Releases Statement Opposing Inclusion of MFN in New CMMI Models\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CCAGW Releases Statement Opposing Inclusion of MFN in New CMMI Models - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\/","og_locale":"en_US","og_type":"article","og_title":"CCAGW Releases Statement Opposing Inclusion of MFN in New CMMI Models - Pharma Trend","og_description":"WASHINGTON–(BUSINESS WIRE)–#congress–Today, Council for Citizens Against Government Waste (CCAGW) President Tom Schatz issued the following statement in response to the announcement of two proposed Center for Medicare and Medicaid Innovation (CMMI) models, \u201cGLOBE\u201d and \u201cGUARD,\u201d that seek to advance so-called \u2018most favored nation\u2019 (MFN) drug price controls: \u201cCCAGW is disappointed to see the administration push ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\/","og_site_name":"Pharma Trend","article_published_time":"2025-12-20T03:06:01+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251219605858\/en\/793198\/22\/CouncilCAGW-Logo-Color.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"CCAGW Releases Statement Opposing Inclusion of MFN in New CMMI Models","datePublished":"2025-12-20T03:06:01+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\/"},"wordCount":315,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251219605858\/en\/793198\/22\/CouncilCAGW-Logo-Color.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\/","url":"https:\/\/pharma-trend.com\/en\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\/","name":"CCAGW Releases Statement Opposing Inclusion of MFN in New CMMI Models - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251219605858\/en\/793198\/22\/CouncilCAGW-Logo-Color.jpg","datePublished":"2025-12-20T03:06:01+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251219605858\/en\/793198\/22\/CouncilCAGW-Logo-Color.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251219605858\/en\/793198\/22\/CouncilCAGW-Logo-Color.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ccagw-releases-statement-opposing-inclusion-of-mfn-in-new-cmmi-models\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"CCAGW Releases Statement Opposing Inclusion of MFN in New CMMI Models"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62390","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62390"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62390\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62390"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62390"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62390"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}